港股異動 | 騰訊半日漲1.83% 帶動恆指上漲46.66點
格隆匯11月5日丨騰訊(0700.HK)今日午間收報333.6港元,漲1.83%,帶動恆指上漲46.66點,暫成交40.1億港元,最新總市值3.2萬億港元。據悉,前日(3日),騰訊在人行科技司開展專題調研時表示將積極參與6部委聯合開展的金融科技應用試點,穩妥推進人臉識別技術線下支付安全應用,並表示目前正與銀行、銀聯攜手打造符合金融行業標準的刷臉支付產品。此外據悉,首屆騰訊醫學ME大會昨日(4日)在京召開,騰訊也打造了專業醫學科普平台——騰訊醫典。騰訊醫療副總裁張猛表示,騰訊醫學ME大會和騰訊醫典只是構築互聯網醫學新科普的第一步,騰訊也將通過持續的努力,為提升國民健康素養做出應有的貢獻。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.